PER 1.41% 7.0¢ percheron therapeutics limited

Ann: Shareholder Newsletter, page-12

  1. 246 Posts.
    lightbulb Created with Sketch. 26
    It appears that CG has poached Dr Andrew McKenzie from CSL with 24 years of clinical trial experience.

    Looking promising ...

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.